The recently established InterAct Network aims to bring together social and economic scientists from across the country with the digital technology and UK manufacturing sectors.
The ESRC-funded network will be supporting and funding collaborative research into issues faced by these industries resulting from the diffusion of new technologies.
The network will be launching its first funding call, a pair of systematic literature reviews, at an upcoming virtual event from 11am – 1pm on 26th January.
Attendees will hear from InterAct co-directors Professor Jan Godsell and Professor Jillian MacBryde as they explain more about the opportunity, the key deadlines, funding availability, application procedure, and other upcoming funding calls in 2022.
Proposals will be accepted for funding up to a maximum of £50,000, with each review to take place over a four-month period. Reviews should address one of the following topics:
- What can we learn from historical and/or international perspectives on industrial development and evolution?
- What impact will the changing nature of business plans have in enabling the adoption of industrial digital technologies?
You can find out more and sign up to the briefing via Eventbrite
More extensive guidance documentation and application forms will be made available on the InterAct Network website and via email following the event.

We’re interested to know what you like about the blog, which posts you find useful and what you’d like to see more of.











BU PhD student attending HIV conference on scholarship
ESRC SWDTP – Applications open for PhD Studentships for September 2026
New paper by CMWH PhD student
Further CMWH contributions to 2026 ICM congress
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease